A Multi-Domain Red Teaming Framework for Safety, Robustness, and Fairness Evaluation of Medical Large Language Models

Researchers developed a comprehensive red teaming framework to evaluate 11 major LLMs across 690 clinically grounded scenarios, revealing that aggregate accuracy scores mask critical safety failures in medical AI systems. The study found that high-performing models (scoring 0.97+) still exhibited complete failures in individual safety-critical cases, and equity-related tasks showed 10-20% error amplification with demographic modifications.

The medical AI safety landscape faces a critical credibility crisis, as this research exposes fundamental limitations in how healthcare institutions currently validate large language models for clinical deployment. Traditional benchmarking approaches using mean accuracy metrics create a false sense of security—models averaging 0.97 performance still produced catastrophic failures on individual clinical scenarios, a finding with direct life-or-death implications for patient safety.

This study addresses an urgent gap in AI governance. Healthcare adoption of LLMs has accelerated dramatically, yet regulatory frameworks and internal validation processes have lagged behind deployment speed. The nine-domain framework spanning 690 scenarios represents the most comprehensive safety evaluation of medical LLMs to date, establishing new standards for clinical AI assessment. The identification of systematic equity failures—10-20% error amplification when demographic variables are modified—reveals that these systems may perpetuate or amplify healthcare disparities, a concern that extends beyond technical performance into social determinants of health.

The findings create meaningful pressure on healthcare organizations and AI developers. Institutions cannot rely solely on vendor benchmarks or published accuracy metrics; they require independent safety validation with clinician oversight. This drives demand for specialized evaluation services and regulatory scrutiny of medical AI deployment. The emphasis on worst-case failure analysis rather than mean performance suggests future regulatory requirements will demand more granular safety reporting.

Looking forward, the hybrid evaluation model combining automated assessment with human-in-the-loop validation likely becomes industry standard for regulated medical AI. Healthcare systems will increasingly demand domain-specific red teaming before deployment, creating opportunities for specialized evaluation providers while raising barriers to market entry for smaller AI developers.

• →High aggregate accuracy scores (0.97+) in medical LLMs mask critical individual safety failures that pose direct clinical risks.
• →Equity-related tasks consistently showed 10-20% error amplification with demographic modifications, indicating systematic fairness vulnerabilities.
• →Hybrid evaluation combining automated scoring with clinician oversight identified clinically relevant failures missed by purely automated assessment.
• →Performance variance across domains matters more for clinical reliability than mean accuracy, fundamentally challenging current validation methodologies.
• →The research establishes new standards for medical AI safety evaluation, likely driving regulatory requirements and institutional validation practices.